<?xml version="1.0" encoding="UTF-8"?>
<Pathway xmlns="http://pathvisio.org/GPML/2013a" Name="Imatinib and chronic myeloid leukemia" Author="Alexander Pico" Organism="Homo sapiens">
  <Comment Source="WikiPathways-description">Hematopoietic Stem Cells found in bone marrow can differentiate into Monocytes and Erythrocytes, or in the case of Chronic Myeloid Leukemia (CML), they can continue to proliferate, undifferentiated, in blood. CML is caused by the Philadelphia translocation (Ph), which puts ABL behind BCR. The BRC-ABL fusion is a constitutively on tyrosine kinase that indirectly counteracts erythroid differentiation, thus promoting the continued proliferation underlying CML. Imatinib is a tyrosine kinase inhibitor that binds ABL and in turn promotes healthy erythroid differentiation by counteracting BRC-ABL activity. Imatinib resistance can be conferred by the over-expression of ABC drug transporters and competitive binding kinases.


The pathway diagram above aligns molecules with the cell fates they promote, to help keep track of inhibition-of-inhibition-of-inhibition sequences, for example. The known mechanisms of imatinib resistance are at the bottom, under CML cell fate and are shown interacting with imatinib, which is under the erythrocyte cell fate. 

Proteins on this pathway have targeted assays available via the [https://assays.cancer.gov/available_assays?wp_id=WP3640 CPTAC Assay Portal]</Comment>
  <BiopaxRef>ada</BiopaxRef>
  <Graphics BoardWidth="851.2095736307595" BoardHeight="855.1837659687451"/>
  <DataNode TextLabel="Erythroid Differentiation" GraphId="a1c1f" Type="Pathway">
    <Graphics ShapeType="None" Color="14961e"/>
    </DataNode>
  <DataNode TextLabel="BCR" GraphId="b42d9" Type="GeneProduct" GroupRef="def18">
        </DataNode>
  <DataNode TextLabel="PVT1" GraphId="dc010" Type="Rna">
    <BiopaxRef>fa6</BiopaxRef>
    <Graphics Color="990099"/>
    </DataNode>
  <DataNode TextLabel="Imatinib" GraphId="e21da" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="ABL1" GraphId="f33e5" Type="GeneProduct" GroupRef="def18">
        </DataNode>
  <DataNode TextLabel="MYC" GraphId="f643d" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="Proliferation" GraphId="fdac3" Type="Pathway">
    <Graphics ShapeType="None" Color="14961e"/>
    </DataNode>
  <DataNode TextLabel="ABCB1" GraphId="a5039" Type="GeneProduct" GroupRef="b41cf">
        </DataNode>
  <DataNode TextLabel="ABCG2" GraphId="c84cf" Type="GeneProduct" GroupRef="b41cf">
        </DataNode>
  <DataNode TextLabel="KIT" GraphId="dc849" Type="GeneProduct" GroupRef="cf86d">
    <BiopaxRef>fa8</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="PDGFRA" GraphId="c52b4" Type="GeneProduct" GroupRef="cf86d">
        </DataNode>
  <DataNode TextLabel="PDGFRB" GraphId="c3992" Type="GeneProduct" GroupRef="cf86d">
        </DataNode>
  <DataNode TextLabel="CDKN1B" GraphId="efd2a" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="G1/S Cell Cycle Transition" GraphId="e860f" Type="Pathway">
    <Graphics ShapeType="None" Color="14961e"/>
    </DataNode>
  <DataNode TextLabel="SKP2" GraphId="f4edb" Type="GeneProduct">
    <BiopaxRef>afc</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="CSF1R" GraphId="a64a2" Type="GeneProduct" GroupRef="cf86d">
        </DataNode>
  <DataNode TextLabel="GADD45A" GraphId="c34a7" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="FOXO3" GraphId="a2e00" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="NOP2" GraphId="c6538" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="SPRED2" GraphId="a3089" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="LYL1" GraphId="dff01" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="PIM1" GraphId="b6e30" Type="GeneProduct" GroupRef="a956a">
        </DataNode>
  <DataNode TextLabel="PIM2" GraphId="ca7a6" Type="GeneProduct" GroupRef="a956a">
        </DataNode>
  <DataNode TextLabel="Monocyte Differentiation" GraphId="f06b0" Type="Pathway">
    <Graphics ShapeType="None" Color="14961e"/>
    </DataNode>
  <DataNode TextLabel="CSF1R" GraphId="dec9a" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="GAB2" GraphId="db476" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="FLT1" GraphId="fde32" Type="GeneProduct">
        </DataNode>
  <Interaction GraphId="id13abe999">
    <Graphics>
      <Point GraphRef="a3089"/>
      <Point GraphRef="a1c1f" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id191040f1">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="e21da"/>
      <Point GraphRef="f33e5" ArrowHead="TBar"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id1c5752cb">
    <Graphics>
      <Point GraphRef="dc010"/>
      <Point GraphRef="f643d" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id2683643d">
    <Graphics>
      <Point GraphRef="d984c"/>
      <Point GraphRef="f4edb" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id3a80c3ab">
    <Graphics>
      <Point GraphRef="dec9a"/>
      <Point GraphRef="db476" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id3d2329da">
    <Graphics>
      <Point GraphRef="dc010"/>
      <Point GraphRef="c6538" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id5efab259">
    <Graphics>
      <Point GraphRef="d098c"/>
      <Point GraphRef="f643d" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id67e2989c">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="c34a7"/>
      <Point GraphRef="e860f" ArrowHead="TBar"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id866e79b0">
    <Graphics>
      <Point GraphRef="e860f"/>
      <Point GraphRef="fdac3" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id8dda123f">
    <Graphics>
      <Point GraphRef="fde32"/>
      <Point GraphRef="f06b0" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id9d1c3af">
    <Graphics>
      <Point GraphRef="a2e00"/>
      <Point GraphRef="c34a7" ArrowHead="mim-transcription-translation"/>
      <Anchor Position="0.15574135199918449" Shape="None" GraphId="d761d"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ida596b9be">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="e62a8" ArrowHead="TBar"/>
      <Point GraphRef="e21da"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idbb626f82">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="f4edb"/>
      <Point GraphRef="efd2a" ArrowHead="TBar"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idbdd8caed">
    <BiopaxRef>f4b</BiopaxRef>
    <Graphics>
      <Point GraphRef="f643d"/>
      <Point GraphRef="dc010" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idcd1cba">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="aca5f"/>
      <Point GraphRef="e21da" ArrowHead="TBar"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idceca0a31">
    <Graphics>
      <Point GraphRef="db476"/>
      <Point GraphRef="f06b0" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idd0010e46">
    <BiopaxRef>cc2</BiopaxRef>
    <Graphics>
      <Point GraphRef="f643d"/>
      <Point GraphRef="d761d" ArrowHead="TBar"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idde44c0a4" GroupRef="def18">
    <Graphics>
      <Point GraphRef="b42d9"/>
      <Point GraphRef="f33e5"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idfb0f0cfb">
    <BiopaxRef>c55</BiopaxRef>
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="f643d"/>
      <Point GraphRef="f4edb" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idfd15878b">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="efd2a"/>
      <Point GraphRef="e860f" ArrowHead="TBar"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e72dd">
    <Graphics>
      <Point GraphRef="dff01"/>
      <Point GraphRef="a1c1f" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bb2d8">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="dff01"/>
      <Point GraphRef="f06b0" ArrowHead="TBar"/>
    </Graphics>
    </Interaction>
  <GraphicalLine GraphId="id6b04de76">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="bff20"/>
      <Point GraphRef="fe23c" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="id74551600">
    <Graphics LineStyle="Broken" Color="999999">
      <Point/>
      <Point/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="bd7c5">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="bff20"/>
      <Point GraphRef="c371f" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="b4a87">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="bff20"/>
      <Point GraphRef="ec183" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <Label TextLabel="Bone Marrow" GraphId="ea51d">
    <Graphics FillColor="ffffff" Color="666666"/>
  </Label>
  <Label TextLabel="Competitive&#10;Binding" GraphId="f9071">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Blood" GraphId="dd52a">
    <Graphics FillColor="ffffff" Color="666666"/>
  </Label>
  <Label TextLabel="Hematopoietic Stem Cell (HSC)" GraphId="abaed">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Differntiated&#10;Erythrocyte" GraphId="e14e4">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Proliferating &#10;CML Cell" GraphId="f252e">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Transport" GraphId="ac17f">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Monocyte" GraphId="b1a7b">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Shape GraphId="bff20">
    <Graphics FillColor="330099" ShapeType="Oval" Color="cc99ff"/>
  </Shape>
  <Shape GraphId="b557e" GroupRef="ce5c5">
    <Graphics FillColor="cc0033" ShapeType="Oval" Color="ff6666"/>
  </Shape>
  <Shape GraphId="d391f" GroupRef="ce5c5">
    <Graphics FillColor="ff6666" ShapeType="Oval" Color="ff6666"/>
  </Shape>
  <Shape GraphId="c371f">
    <Graphics FillColor="cc0066" ShapeType="Oval" Color="cc99ff"/>
  </Shape>
  <Shape GraphId="fcaa4" GroupRef="eed64">
    <Graphics FillColor="cc99ff" ShapeType="Oval" Color="cc99ff"/>
  </Shape>
  <Shape GraphId="bca37" GroupRef="eed64">
    <Graphics FillColor="6600cc" ShapeType="Oval" Color="6600cc"/>
  </Shape>
  <Shape GraphId="d8685" GroupRef="eed64">
    <Graphics FillColor="6600cc" ShapeType="Oval" Color="6600cc"/>
  </Shape>
  <Group GroupId="b41cf" GraphId="aca5f" Style="Group">
    <BiopaxRef>a7c</BiopaxRef>
  </Group>
  <Group GroupId="d09b6" GraphId="afafb" Style="Group"/>
  <Group GroupId="e4fd2" GraphId="b4023" Style="Group"/>
  <Group GroupId="a956a" GraphId="d098c" Style="Group"/>
  <Group GroupId="def18" GraphId="d984c" Style="Group"/>
  <Group GroupId="cf86d" GraphId="e62a8" Style="Group">
    <BiopaxRef>b35</BiopaxRef>
  </Group>
  <Group GroupId="eed64" GraphId="ec183" Style="Group"/>
  <Group GroupId="ecaa9" GraphId="f052e" Style="Group"/>
  <Group GroupId="ce5c5" GraphId="fe23c" Style="Group"/>
  <InfoBox/>
  <Biopax>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >erythrocyte</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >CL:0000232</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Cell Type</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cc2">
      <bp:ID >21835778</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Myc and PI3K/AKT signaling cooperatively repress FOXO3a-dependent PUMA and GADD45a gene expression.</bp:TITLE>
      <bp:SOURCE >Nucleic Acids Res</bp:SOURCE>
      <bp:YEAR >2011</bp:YEAR>
      <bp:AUTHORS >Amente S</bp:AUTHORS>
      <bp:AUTHORS >Zhang J</bp:AUTHORS>
      <bp:AUTHORS >Lavadera ML</bp:AUTHORS>
      <bp:AUTHORS >Lania L</bp:AUTHORS>
      <bp:AUTHORS >Avvedimento EV</bp:AUTHORS>
      <bp:AUTHORS >Majello B</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c55">
      <bp:ID >22710719</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >MYC antagonizes the differentiation induced by imatinib in chronic myeloid leukemia cells through downregulation of p27(KIP1.).</bp:TITLE>
      <bp:SOURCE >Oncogene</bp:SOURCE>
      <bp:YEAR >2013</bp:YEAR>
      <bp:AUTHORS >G&#243;mez-Casares MT</bp:AUTHORS>
      <bp:AUTHORS >Garc&#237;a-Alegria E</bp:AUTHORS>
      <bp:AUTHORS >L&#243;pez-Jorge CE</bp:AUTHORS>
      <bp:AUTHORS >Ferr&#225;ndiz N</bp:AUTHORS>
      <bp:AUTHORS >Blanco R</bp:AUTHORS>
      <bp:AUTHORS >Alvarez S</bp:AUTHORS>
      <bp:AUTHORS >Vaqu&#233; JP</bp:AUTHORS>
      <bp:AUTHORS >Bretones G</bp:AUTHORS>
      <bp:AUTHORS >Caraballo JM</bp:AUTHORS>
      <bp:AUTHORS >S&#225;nchez-Bail&#243;n P</bp:AUTHORS>
      <bp:AUTHORS >Delgado MD</bp:AUTHORS>
      <bp:AUTHORS >Mart&#237;n-Perez J</bp:AUTHORS>
      <bp:AUTHORS >Cigudosa JC</bp:AUTHORS>
      <bp:AUTHORS >Le&#243;n J</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >myeloid leukocyte</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >CL:0000766</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Cell Type</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >disease pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0000013</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >chronic myeloid leukemia pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0000710</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >chronic myeloid leukemia</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:8552</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b35">
      <bp:ID >16485879</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A comprehensive review of imatinib mesylate (Gleevec) for dermatological diseases.</bp:TITLE>
      <bp:SOURCE >J Drugs Dermatol</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:AUTHORS >Scheinfeld N</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a7c">
      <bp:ID >21163869</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Drug transporters and imatinib treatment: implications for clinical practice.</bp:TITLE>
      <bp:SOURCE >Clin Cancer Res</bp:SOURCE>
      <bp:YEAR >2011</bp:YEAR>
      <bp:AUTHORS >Eechoute K</bp:AUTHORS>
      <bp:AUTHORS >Sparreboom A</bp:AUTHORS>
      <bp:AUTHORS >Burger H</bp:AUTHORS>
      <bp:AUTHORS >Franke RM</bp:AUTHORS>
      <bp:AUTHORS >Schiavon G</bp:AUTHORS>
      <bp:AUTHORS >Verweij J</bp:AUTHORS>
      <bp:AUTHORS >Loos WJ</bp:AUTHORS>
      <bp:AUTHORS >Wiemer EA</bp:AUTHORS>
      <bp:AUTHORS >Mathijssen RH</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ada">
      <bp:ID >15573099</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Strategies to overcome resistance to targeted protein kinase inhibitors.</bp:TITLE>
      <bp:SOURCE >Nat Rev Drug Discov</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Daub H</bp:AUTHORS>
      <bp:AUTHORS >Specht K</bp:AUTHORS>
      <bp:AUTHORS >Ullrich A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >hematopoietic stem cell</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >CL:0000037</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Cell Type</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="afc">
      <bp:ID >15833859</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27Kip1 degradation and proliferation of chronic myelogenous leukemia cells.</bp:TITLE>
      <bp:SOURCE >Cancer Res</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Andreu EJ</bp:AUTHORS>
      <bp:AUTHORS >Lled&#243; E</bp:AUTHORS>
      <bp:AUTHORS >Poch E</bp:AUTHORS>
      <bp:AUTHORS >Ivorra C</bp:AUTHORS>
      <bp:AUTHORS >Albero MP</bp:AUTHORS>
      <bp:AUTHORS >Mart&#237;nez-Climent JA</bp:AUTHORS>
      <bp:AUTHORS >Montiel-Duarte C</bp:AUTHORS>
      <bp:AUTHORS >Rif&#243;n J</bp:AUTHORS>
      <bp:AUTHORS >P&#233;rez-Calvo J</bp:AUTHORS>
      <bp:AUTHORS >Arbona C</bp:AUTHORS>
      <bp:AUTHORS >Pr&#243;sper F</bp:AUTHORS>
      <bp:AUTHORS >P&#233;rez-Roger I</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fa6">
      <bp:ID >25883951</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >PVT1: a rising star among oncogenic long noncoding RNAs.</bp:TITLE>
      <bp:SOURCE >Biomed Res Int</bp:SOURCE>
      <bp:YEAR >2015</bp:YEAR>
      <bp:AUTHORS >Colombo T</bp:AUTHORS>
      <bp:AUTHORS >Farina L</bp:AUTHORS>
      <bp:AUTHORS >Macino G</bp:AUTHORS>
      <bp:AUTHORS >Paci P</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f4b">
      <bp:ID >17503467</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The PVT-1 oncogene is a Myc protein target that is overexpressed in transformed cells.</bp:TITLE>
      <bp:SOURCE >J Cell Physiol</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Carramusa L</bp:AUTHORS>
      <bp:AUTHORS >Contino F</bp:AUTHORS>
      <bp:AUTHORS >Ferro A</bp:AUTHORS>
      <bp:AUTHORS >Minafra L</bp:AUTHORS>
      <bp:AUTHORS >Perconti G</bp:AUTHORS>
      <bp:AUTHORS >Giallongo A</bp:AUTHORS>
      <bp:AUTHORS >Feo S</bp:AUTHORS>
    </bp:PublicationXref>
  </Biopax>
</Pathway>